COVID-19 vaccine shows positive results and moves to larger studies
Massachusett’s biotech Moderna’s early results from a phase 1 trial showed the vaccine was safe and prompted an immune response in humans. read here
Massachusett’s biotech Moderna’s early results from a phase 1 trial showed the vaccine was safe and prompted an immune response in humans. read here